NDC 69117-0019-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69117-0019
- Requested NDC
- 69117-0019-01
- Package NDCs from labels
- 69117-0019-1, 69117-0019-2, 69117-0019-01
- Manufacturer
- YILING PHARMACEUTICAL, INC.
- Effective date
- 2025-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - YILING PHARMACEUTICAL, INC. | YILING PHARMACEUTICAL, INC. | 2025-12-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| ACYCLOVIR TABLETS, USP 800 mg | Redpharm Drug, inc. | 2024-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2021-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2020-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - REMEDYREPACK INC. | REMEDYREPACK INC. | 2019-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69117-0019-1 | Acyclovir | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 69117-0019-2 | Acyclovir | 500 in 1 BOTTLE | TABLET | 500 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69117-0019 | ACYCLOVIR TABLET [YILING PHARMACEUTICAL, INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250101_67e7b340-0635-2595-e053-2a91aa0ad266.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69117-0019-1 | EA - Each | 69117-0019 | df9ed45f-6070-455c-aa96-c825a9732341 | 1 | 2018-09-05 |
| 69117-0019-2 | EA - Each | 69117-0019 | 69ac961d-b9af-4fe3-a410-c7d4e674013f | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 97ed8713-4b3e-48a9-92c0-0a98ecf0485c | 2024-01-01 | Warnings, Adverse reactions | ANDA210401 X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | e4f91376-9e18-41a4-aa5e-adcea0c625d9 | 2023-12-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bionpharma Inc. | 6f1db9f0-9b41-4fb7-8798-44fdc2c128df | 2023-12-03 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir suspension | ACYCLOVIR | Novadoz Pharmaceuticals LLC | 3efa1e5e-5a14-4724-a2ca-25702f10faed | 2023-11-03 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | 942632d8-08cd-4003-aec0-1c6d5c09bc15 | 2023-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | SQUARE PHARMACEUTICALS LIMITED | b24201ea-aeae-4de1-b01b-eee89068e786 | 2023-07-02 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e8433261-07f1-448b-aaf4-631414598c08 | 2023-05-08 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | c40a57b9-4cf1-4a69-abf3-eb99a7fcda00 | 2023-04-16 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 34a38cdf-04e8-4006-a9f5-4a0831117d61 | 2023-02-06 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| f14d5ca9-5639-9d38-e053-2995a90aec90 | 95fa2903-44c3-1d5f-e053-2a95a90a4a82 | 2023-01-02 | Warnings, Adverse reactions | 95fa2903-44c3-1d5f-e053-2a95a90a4a82 | ||
| Acyclovir | ACYCLOVIR | Modavar Pharmaceuticals LLC | 8de9c4f3-b800-4419-a063-8b62a0cba0fa | 2022-12-29 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Quinn Pharmaceuticals | 9ad711e4-003d-4b58-8177-32928bc42aa9 | 2022-12-20 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | d824fc07-9f03-4cb2-9bf8-ff7cc2955255 | 2022-10-09 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | 8fb01f23-e2bd-6850-e053-2995a90a7cc5 | 2022-10-09 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | 12df1991-fb1c-45df-acf3-706b1e8ecfc3 | 2022-10-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 2ca1395f-96b4-4543-8eed-bd07c62bbc7c | 2022-09-12 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | e8056ec6-d2dc-48af-8550-82726af1c5c5 | 2022-08-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 9e5b3a11-9c4b-4998-8a18-3046af1314ab | 2022-06-01 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 33630a35-346e-43b6-9286-89e28ac0094a | 2022-06-01 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | c55bde35-a202-4c25-b545-e5d5e95c1175 | 2022-04-01 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.